Boston Children's Hospital Accelerates Data-Driven Approach to Clinical Research by Joining the TriNetX Global Health Research Network

CAMBRIDGE, Mass., Feb. 20, 2018 /PRNewswire/ -- Boston Children's Hospital, the top ranked pediatric hospital in the nation according to U.S. News and World Report, has joined the TriNetX global health research network to further its efforts at bringing a more data-driven approach to clinical research. The trend in the healthcare industry is to gain access to a wider pool of patient data in an effort to accelerate the study start-up process and identification of patients for clinical trials. Boston Children's Hospital is live on the network, as of February 1, 2018.

"Infusing a data-driven approach into the conversation between research institutions and industry provides great efficiencies, but most importantly, it gives our patients the opportunity to potentially participate in clinical trials they otherwise wouldn't be aware of," said Piotr Sliz, Chief Research Information Officer at Boston Children's Hospital. "Being part of the TriNetX network allows us to collaborate around the globe with other researchers at biopharmaceutical companies who are working on new therapies that our patients need."

TriNetX is the global health research network that enables healthcare organizations, biopharmaceutical companies and Contract Research Organizations (CROs) to collaborate, enhance trial design, accelerate patient identification for recruitment, and conduct in-depth research through the sharing of clinical, oncology and genomic data mapped to a common data model.

Network members utilize TriNetX's cloud-based, health research platform to analyze patient populations and perform "what-if" analyses in real-time. As members, healthcare organizations receive hardware and software that are configured within the organization's IT infrastructure and often builds on existing data resources such as i2b2 and Observational Medical Outcomes Partnership (OMOP). Researchers then have access to the institution's de-identified patient data through a user-friendly interface and a growing number of visualization and analysis capabilities. Biopharmaceutical companies and CROs are presented with aggregate views, but each data point in the TriNetX network can be traced to healthcare organizations who have the ability to identify individual patients, allowing clinical researchers to develop virtual patient cohorts that can then be re-identified for potential recruitment into a clinical trial.

"TriNetX provides us with a responsive, modern interface that provides sophisticated visualizations to present our internal data to investigators at Boston Children's," said Sliz. "It is also beneficial that TriNetX is involved with several i2b2 research data warehouse projects in our community here in Boston." 

Boston Children's is home to the largest research program at a pediatric medical center in the world and invests heavily in research focused on accelerating new treatments for devastating diseases. Their discoveries translate from the laboratory bench to the patient's bedside where they have been improving the health of children and adults since 1869.

"TriNetX is honored to welcome Boston Children's to the network and we look forward to supporting their efforts to transform the collaborative research process," said Gadi Lachman, President & CEO of TriNetX. "We believe this collaboration will play an important role in bringing new therapies to pediatric patients in need."

About Boston Children's Hospital 
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 11 members of the Institute of Medicine and 10 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 415-bed comprehensive center for pediatric and adolescent health care. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information, visit http://www.childrenshospital.org/.

About TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) to collaborate, improve research, enhance trial design, accelerate recruitment and bring new therapies to market faster. Each member of our community shares in the consolidated value of our global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study. For more information, visit TriNetX at http://www.trinetx.com/ or follow @TriNetX on Twitter.

Media Contacts

Julia Weber
Racepoint Global
(617) 624-3234
[email protected]

Keri Stedman
Boston Children's Hospital
(617) 919-3110
[email protected]

SOURCE TriNetX

Related Links

http://www.trinetx.com